RADICALS is a large-scale randomised controlled trial for men with prostate cancer. The aim is to compare adjuvant versus early selective salvage treatment following a radical prostatectomy.
The trial is designed by the NCRI prostate Clinical Studies Group and the MRC Clinical Trials Unit. It is a collaboration between the MRC CTU and the National Cancer Institute of Canada Clinical Trials Group (NCIC CTG). The trial has been recruiting in the UK since November 2007 and we are pleased to announce that the first Canadian patient was entered in July 2008.